Breath Diagnostics, Inc. (BDx) is a Louisville, Kentucky-based company formed in October 2014 to commercialize its revolutionary OneBreath™ technology.  The company’s mission is to implement breath analysis technology globally to provide early cancer detection and reduce patient exposure to expensive, high-risk medical procedures.

The corporate objective is to launch OneBreath™ for lung cancer detection and ultimately expand the use of this technology to detect other cancers and diseases.  The first objective is to complete FDA enabling trials.  The company will develop its corporate footprint in collaboration with one or more CLIA certified labs, which will serve as a partner in the development of BDx’s technology.